Meeting
2024 ASCO Genitourinary Cancers Symposium
The 340B Drug Pricing Program and oral specialty drugs for advanced prostate cancer.
Authors
Kassem S Faraj
University of Michigan, Ann Arbor, MI
Kassem S Faraj , Samuel Kaufman , Lindsey A. Herrel , Mary Oerline , Megan Veresh Caram , Vahakn B. Shahinian , Brent K. Hollenbeck
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Cancer Disparities
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 26)
DOI
10.1200/JCO.2024.42.4_suppl.26
Abstract #
26
Poster Bd #
A5
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Financial hardship among Medicare beneficiaries prescribed oral targeted therapies for advanced prostate cancer.
First Author: Megan Veresh Caram
Poster
2024 ASCO Quality Care Symposium
Elevating the patient voice: Understanding treatment preferences in patients with advanced prostate cancer.
First Author: Elizabeth R. Kessler
Poster
2023 ASCO Quality Care Symposium
Comparative cost-effectiveness analysis of oral agents for advanced EGFR mutated and ALK-positive non-small cell lung cancer.
First Author: Dali Edwards
Poster
2023 ASCO Genitourinary Cancers Symposium
Patient perceptions regarding the process of obtaining oral prostate cancer medications.
First Author: Eric B Schwartz